康西普治療公司
DE ˙ DB ˙ US2183521028
€63.98 ↑2.18 (3.53%)
2026-06-04
分享價格
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership19,524 shares
Latest Disclosed Value $ 787,012
Engineers Gate Manager LP ownership in HTD / Corcept Therapeutics Incorporated

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 19,524 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $673,383 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 14, 2025 disclosing 0 shares of Corcept Therapeutics Incorporated. The current value of the position is $1,249,146 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 19,524 19,524 787 0.0098
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -19,002 -100.00 0 -100.00
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 19,002 -31,134 -62.10 2,170 -14.09 0.0366
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 50,136 -6,073 -10.80 2,526 -2.88 0.0440
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 56,209 -97,180 -63.36 2,601 -47.80 0.0508
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 153,389 -53,362 -25.81 4,984 -4.32 0.1124
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 206,751 195,541 1,744.34 5,208 1,330.77 0.1371
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 11,210 -4,476 -28.53 364 -14.75 0.0104
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 15,686 -16,877 -51.83 427 -41.02 0.0158
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 32,563 32,563 725 0.0274
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -29,573 -100.00 0 -100.00
2023-02-14 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 29,573 29,573 601 0.0361
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -13,577 -100.00 0 -100.00
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 13,577 -8,189 -37.62 306 -29.00 0.0120
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 21,766 21,766 431 0.0194
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -18,045 -100.00 0 -100.00
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 18,045 2,508 16.14 397 7.30 0.0255
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 15,537 -12,337 -44.26 370 -49.25 0.0183
2021-02-16 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 27,874 27,874 729 0.0316
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -52,827 -100.00 0 -100.00
2020-08-17 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 52,827 1,552 3.03 889 45.74 0.0452
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 51,275 -89,838 -63.66 610 -64.26 0.0439
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 141,113 115,830 458.13 1,707 378.15 0.0751
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 25,283 -48,879 -65.91 357 -56.83 0.0181
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 74,162 -53,007 -41.68 827 -44.61 0.0457
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 127,169 74,686 142.31 1,493 112.98 0.0904
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 52,483 9,144 21.10 701 15.30 0.0561
2018-11-01 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 43,339 29,819 220.55 608 185.45 0.0467
2018-08-03 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 13,520 13,520 213 0.0166
2018-05-07 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -85,654 -100.00 0 -100.00
2018-02-01 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 85,654 85,654 1,547 0.1062
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.